News& Press Releases

Offspring Biosciences offers support services for businesses in preclinical and clinical drug development. – We help our customers make new drugs available to patients faster, safer, and at a lower cost, says Anders Dahlstrand, CEO of the company. Offspring Biosciences operates in the rapidly growing CRO industry (Contract Research Organization) and assists pharmaceutical and biotech companies by conducting preclinical and clinical studies required for regulatory approvals. O

We are happy to welcome Åsa Johansson to Offspring Biosciences as our new Head of Operations. Åsa will have the responsibility for overseeing HR, Finance, and Operations.  Åsa has over ten years of experience in leading positions. She has navigated roles in both the public and private sectors, along with academia. Her expertise spans over more than two decades within the field of clinical microbiology and medical biochemistry. Skilled in an array of laboratory techniques incl

Unlocking the combined value of Offspring’s innovative pre-clinical solutions with Flagship’s clinical trial data-driven assay solutions Broomfield, CO, USA and Södertälje, Sweden – January 24, 2024 Flagship Biosciences, a leader in spatial biology and biomarker analytics services, and Offspring Biosciences, an innovator in pre-clinical biomarker assay solutions, today announced a strategic partnership that aims to further advance precision drug development with a complete bi